Zura Bio Limited成立於2022年1月。該公司是一家臨床階段、多資產免疫學公司,致力於為一系列未滿足需求的自身免疫和炎症性疾病開發新型雙通路抗體。憑藉團隊的豐富經驗,公司識別相關疾病,並在這些疾病中開發差異化資產。公司戰略重點是利用雙通路生物的力量,為自身免疫性和炎症性疾病患者提供更廣泛、更深層次的臨床獲益。
董事
名稱
職位
Amit D. Munshi
Chairman of the Board
Robert Lisicki
Chief Executive Officer and Director
Arnout Ploos van Amstel
Independent Director
Daniel Becker
Independent Director
Jennifer Ann Jarrett
Independent Director
Neil Graham
Independent Director
Sandeep C. Kulkarni
Independent Director
Steven J. Schoch
Independent Director
Someit Sidhu
Director
股東
名稱
職位
Robert Lisicki
Chief Executive Officer and Director
Kimberly Ann Davis
Chief Operating Officer, Secretary and Chief Legal Officer